专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20230090069A1 LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS 有权
公开(公告)号：US20230090069A1
公开(公告)日：2023-03-23
申请号：US17904734
申请日：2021-03-05
申请人： CENTRE HOSPITALIER UNIVERSITAIRE DE NIMES , HUMANITAS MIRASOLE SPA , THE UNIVERSITY OF SUSSEX , KING'S COLLEGE LONDON , QUEEN MARY UNIVERSITY OF LONDON , SORBONNE UNIVERSITE , ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS , THE UNIVERSITY OF SHEFFIELD
发明人： Gilbert BENSIMON , Peter Nigel LEIGH , Timothy TREE , Cecilia GARLANDA , Massimo LOCATI , Janine KIRBY , Pamela SHAW , Andrea MALASPINA
IPC分类号： A61K38/20 , A61K31/428 , A61P25/28
摘要： The present invention is in the field of amyotrophic lateral sclerosis (ALS) and relates to human interleukin-2 (IL-2) for use in the treatment of amyotrophic lateral sclerosis in a human subject, wherein each dose of human IL-2 administered to said subject is between 0.1×106 to 3×106 international units (IU) Human IL-2 is preferably administered in cycles of 3 to 7 days of once-daily sub-cutaneous injection of 0.1×106 to 3×106 HI human IL-2. The treatment does not comprise the administration of regulatory T cells to the subject, who is preferably also under riluzole treatment. The administered human IL-2 is preferably not complexed with anti-hIL-2 antibodies and the treatment also preferably does not comprise the administration of rapamycin or any other suppressive agent of effector T cells (Teffs) to the subject. The treatment permits to decrease plasma CCL2 concentration and to change the polarization of blood macrophages from an M1 inflammatory phenotype to an anti-inflammatory M2 phenotype involved in tissue repair.

2. 发明申请

US20230000913A1 IMMUNORESPONSIVE CELLS ARMOURED WITH SPATIOTEMPORALLY RESTRICTED ACTIVITY OF CYTOKINES OF THE IL-1 SUPERFAMILY 有权
公开(公告)号：US20230000913A1
公开(公告)日：2023-01-05
申请号：US17634720
申请日：2020-08-13
申请人： King's College London
发明人： John MAHER , Caroline Malai HULL
IPC分类号： A61K35/17 , C07K14/545 , C12N5/0783 , C12N9/64
摘要： Provided herein are immunoresponsive cells having IL-1 superfamily activities with spatiotemporal restriction. The immunoresponsive cells can further express a protease for regulating the IL-1 superfamily activities, and a chimeric antigen receptor (CAR) or a parallel CAR. Also provided herein are methods of preparing the immunoresponsive cells and methods of directing T cell mediated immune response using the immunoresponsive cells.

3. 发明申请

US20220343605A1 COMPUTER IMPLEMENTED METHOD AND SYSTEM FOR NAVIGATION AND DISPLAY OF 3D IMAGE DATA 有权
公开(公告)号：US20220343605A1
公开(公告)日：2022-10-27
申请号：US17763728
申请日：2020-09-25
申请人： Guy's and St. Thomas' NHS Foundation Trust , King's College London
发明人： John MUNRO SIMPSON , Kuberan PUSHPARAJAH , Alberto GÓMEZ HERRERO , Julia Anne SCHNABEL , Gavin WHEELER , Shujie DENG , Nicolas TOUSSAINT
IPC分类号： G06T19/00 , G06T19/20 , G06F3/04815 , G06F3/04845
摘要： A computer-implemented method and system for navigation and display of 3D image data is described. In the method, a 3D image dataset to be displayed is retrieved and a highlight position is identified within the 3D image dataset. A scalar opacity map is calculated for the 3D image dataset, the opacity map having a value for each of a plurality of positions in the 3D image dataset, the respective value being dependent on the respective position relative to the highlight position, and on the value of the 3D image at the respective position relative to the value of the 3D image at the highlight position. The opacity is applied to the 3D image dataset to generate a modified 3D image view.

4. 发明授权

US11454692B2 Method of performing magnetic resonance imaging and a magnetic resonance apparatus 有权
公开(公告)号：US11454692B2
公开(公告)日：2022-09-27
申请号：US16108573
申请日：2018-08-22
申请人： Siemens Healthcare Limited , King's College London
发明人： Rene Botnar , Giulia Ginami , Radhouene Neji , Claudia Prieto
IPC分类号： G01R33/567 , G01R33/48 , G01R33/56 , G01R33/50 , G01R33/36 , G01R33/561
摘要： In a method of performing magnetic resonance (MR) imaging, an MR apparatus, and a computer-readable medium during a first cardiac cycle of a subject, a first imaging sequence is generated for application to a subject. The first imaging sequence has a preparatory pulse and an inversion recovery pulse following the preparatory pulse. First signals emitted from the subject in response to the first imaging sequence are detected, and first image data are generated based on the first signals. During a second cardiac cycle following the first cardiac cycle, a second imaging sequence is generated for application to the subject. The second imaging sequence has a preparatory pulse. Second signals emitted from the subject in response to the second imaging sequence are detected, and second image data are generated based on the second signals.

5. 发明申请

US20220298223A1 B CELL TARGETED PARALLEL CAR (pCAR) THERAPEUTIC AGENTS 有权
公开(公告)号：US20220298223A1
公开(公告)日：2022-09-22
申请号：US17638742
申请日：2020-08-28
申请人： KING'S COLLEGE LONDON
发明人： John MAHER , Leena HALIM
IPC分类号： C07K14/725 , C07K16/28
摘要： Provided herein are immuno-responsive cells expressing a B cell targeting pCAR comprising a 2nd generation chimeric antigen receptor (CAR) and a chimeric co-stimulatory receptor (CCR). Also provided herein are methods of preparing the immuno-responsive cells and methods of directing T cell mediated immune response using the immuno-responsive cells.

6. 发明申请

US20220172328A1 IMAGE RECONSTRUCTION 有权
公开(公告)号：US20220172328A1
公开(公告)日：2022-06-02
申请号：US17601135
申请日：2020-04-02
申请人： KING'S COLLEGE LONDON
发明人： Andrew J. Reader
IPC分类号： G06T5/00 , H04N5/21
摘要： A method of creating an image representative of a measured dataset by iteratively updating a base image includes: generating a principal dataset from the measured dataset, the principal dataset having noise at substantially the same level as the measured dataset; generating an additional dataset from the measured dataset such that the additional dataset has noise at substantially the same level as the measured dataset and is not identical to the principal dataset; processing the base image without noise compensation using the principal dataset and additional dataset to obtain a principal interim image and an additional interim image; comparing the principal and the additional interim image to determine an indication of a noise level present; and using the determined indication of noise present to select noise compensation to apply when processing the base image using the measured dataset to create a new base image representative of the measured dataset.

7. 发明申请

US20220152103A1 MUC1 PARALLEL CAR (pCAR) THERAPEUTIC AGENTS 有权
公开(公告)号：US20220152103A1
公开(公告)日：2022-05-19
申请号：US17435976
申请日：2020-03-11
申请人： LEUCID BIO LTD , KING'S COLLEGE LONDON
发明人： John MAHER , Lynsey WHILDING , Fahima KAUSAR , Leena HALIM , Tamara MULIADITAN , Maya GLOVER
IPC分类号： A61K35/17 , A61P35/00 , C12N5/0783 , C12N15/113
摘要： Provided herein are immunoresponsive cells expressing a MUC1 targeting pCAR comprising a second generation chimeric antigen receptor (CAR) and a chimeric co-stimulatory receptor (CCR). Also provided herein are methods of preparing the immunoresponsive cells and methods of directing T cell mediated immune response using the immunoresponsive cells.

8. 发明授权

US11275142B1 System and method for performing motion-insensitive and quiet three-dimensional magnetic resonance imaging 有权
公开(公告)号：US11275142B1
公开(公告)日：2022-03-15
申请号：US17090557
申请日：2020-11-05
申请人： GE PRECISION HEALTHCARE LLC , KING'S COLLEGE LONDON
发明人： Florian Wiesinger , Ana Beatriz Solana Sanchez , Anne Menini , Emil Albert Ljungberg , Tobias Charles Wood , Gareth John Barker , Steven Charles Williams
IPC分类号： G01R33/565 , G01R33/56 , G01R33/567 , G06T11/00 , G01R33/48
摘要： A method for generating motion-corrected medical images includes obtaining, via a processor, k-space data of a region of interest acquired by a magnetic resonance imaging system utilizing a 3D radial pulse sequence with ZTE acquisition including optional magnetization preparation pulses. The method also includes sampling, via the processor, the k-space data to obtain a plurality of interleaved k-space segments. The method further includes reconstructing, via the processor, one or more interleaved k-space segments of the plurality of interleaved k-space segments to generate a respective motion navigator volume. The method even further includes co-registering, via the processor, each respective motion navigator volume to estimate motion and performing motion correction on the one or more interleaved k-space segments and their corresponding k-space trajectories. The method still further includes generating, via the processor, a motion-corrected volume from all of the motion corrected interleaved k-space segments and their corresponding motion corrected k-space trajectories.

9. 发明申请

US20220062340A1 IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS 有权
公开(公告)号：US20220062340A1
公开(公告)日：2022-03-03
申请号：US17415485
申请日：2019-12-19
申请人： KING'S COLLEGE LONDON
发明人： Rimma GOLDBERG , Graham LORD
IPC分类号： A61K35/17 , A61P37/06 , A61P1/00 , C12N5/0783
摘要： This invention relates to immunotherapeutic methods involving administering immunoregulatory T cells (Tregs) with improved function to a subject. The invention also concerns modified Tregs having improved function and pharmaceutical compositions comprising the same. The improved Tregs of the invention have the capacity for increased gut-homing, amongst other improved functions. The methods and compositions of the invention are particularly useful in the treatment of immune-mediated gut disorders.

10. 发明申请

US20210361736A1 VISTA ANTAGONIST AND METHODS OF USE 有权
公开(公告)号：US20210361736A1
公开(公告)日：2021-11-25
申请号：US17186199
申请日：2021-02-26
申请人： KING'S COLLEGE LONDON , THE TRUSTEES OF DARTMOUTH COLLEGE
发明人： Randolph J. NOELLE , Sabrina CEERAZ , Isabelle LEMERCIER , Elizabeth NOWAK , Janet LINES , Li WANG , Mark SPALLER
IPC分类号： A61K38/10 , C07K7/08 , A61K45/06 , A61K9/00 , A61K39/00 , C07K16/28 , G01N33/566
摘要： The present invention is directed to a peptide, multimer, conjugate, analog, derivative or mimetic thereof that inhibits the activity of VISTA. The invention further contemplates therapeutic use of the VISTA antagonist peptide, multimer, conjugate, derivative or mimetic thereof, including treating or preventing cancer, bacterial infections, viral infections, parasitic infections and fungal infections, as well as research uses of the antagonist.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式